A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors

Summary

This single-armed, open, phase I study was designed to evaluate the safety and tolerance of ReT01 ACT injection in the treatment of advanced solid tumors. The phase I clinical trial is expected to be finished in 1 year.

Timeline

Start

2024-04-08

Primary completion

2025-02-18

Completion

2027-02-18

Drugs

Indications